Tokyo Tape
Sign in
← Medical Ikkou Group

Annual report

3353.TEDINET S100THFR
Period2023-03-01 → 2024-02-29
Filed2024-05-23
StandardJapan GAAP
ConsolidatedYes
Data checks22 of 22 passed
Key figures · 145
MetricValuePeriodScopeSource row
Revenue¥39.9bn2023-03-01 → 2024-02-29Cons.Net sales
Revenue¥33.9bn2022-03-01 → 2023-02-28Cons.Net sales
Revenue¥33.6bn2021-03-01 → 2022-02-28dCons.Net sales (5-year summary)
Revenue¥31.6bn2020-03-01 → 2021-02-28dCons.Net sales (5-year summary)
Revenue¥32.0bn2019-03-01 → 2020-02-29dCons.Net sales (5-year summary)
Operating income¥1.6bn2023-03-01 → 2024-02-29Cons.Operating income
Operating income¥935m2022-03-01 → 2023-02-28Cons.Operating income
Ordinary income¥1.8bn2023-03-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥1.2bn2022-03-01 → 2023-02-28Cons.Ordinary income
Ordinary income¥1.4bn2021-03-01 → 2022-02-28dCons.Ordinary income loss (5-year summary)
Ordinary income¥1.2bn2020-03-01 → 2021-02-28dCons.Ordinary income loss (5-year summary)
Ordinary income¥1.2bn2019-03-01 → 2020-02-29dCons.Ordinary income loss (5-year summary)
Profit before tax¥1.7bn2023-03-01 → 2024-02-29Cons.Income before income taxes
Profit before tax¥1.3bn2022-03-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥1.0bn2023-03-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥760m2022-03-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥852m2021-03-01 → 2022-02-28dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥835m2020-03-01 → 2021-02-28dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥802m2019-03-01 → 2020-02-29dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥1.1bn2023-03-01 → 2024-02-29Cons.Profit loss
Net income¥773m2022-03-01 → 2023-02-28Cons.Profit loss
Total assets¥31.7bnat 2024-02-29Cons.Assets
Total assets¥27.5bnat 2023-02-28Cons.Assets
Total assets¥29.1bnat 2022-02-28dCons.Total assets (5-year summary)
Total assets¥28.6bnat 2021-02-28dCons.Total assets (5-year summary)
Total assets¥26.2bnat 2020-02-29dCons.Total assets (5-year summary)
Total liabilities¥17.8bnat 2024-02-29Cons.Liabilities
Total liabilities¥14.9bnat 2023-02-28Cons.Liabilities
Net assets / equity¥13.8bnat 2024-02-29Cons.Net assets
Net assets / equity¥12.6bnat 2023-02-28Cons.Net assets
Net assets / equity¥11.9bnat 2022-02-28dCons.Net assets
Net assets / equity¥10.5bnat 2021-02-28dCons.Net assets (5-year summary)
Net assets / equity¥10.2bnat 2020-02-29dCons.Net assets (5-year summary)
Cash and deposits¥7.7bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥6.4bnat 2023-02-28Cons.Cash and deposits
Cash & equivalents¥7.6bnat 2024-02-29Cons.Cash and cash equivalents
Cash & equivalents¥6.3bnat 2023-02-28Cons.Cash and cash equivalents
Cash & equivalents¥7.8bnat 2022-02-28dCons.Cash and cash equivalents
Cash & equivalents¥6.8bnat 2021-02-28dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥5.6bnat 2020-02-29dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥4.3bn2023-03-01 → 2024-02-29Cons.Net cash provided by used in operating activities
Operating cash flow¥1.3bn2022-03-01 → 2023-02-28Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2021-03-01 → 2022-02-28dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.8bn2020-03-01 → 2021-02-28dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.8bn2019-03-01 → 2020-02-29dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥3.2bn2023-03-01 → 2024-02-29Cons.Net cash provided by used in investment activities
Investing cash flow−¥478m2022-03-01 → 2023-02-28Cons.Net cash provided by used in investment activities
Investing cash flow−¥216m2021-03-01 → 2022-02-28dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.2bn2020-03-01 → 2021-02-28dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥375m2019-03-01 → 2020-02-29dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow¥278m2023-03-01 → 2024-02-29Cons.Net cash provided by used in financing activities
Financing cash flow−¥2.4bn2022-03-01 → 2023-02-28Cons.Net cash provided by used in financing activities
Financing cash flow¥65m2021-03-01 → 2022-02-28dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥591m2020-03-01 → 2021-02-28dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.1bn2019-03-01 → 2020-02-29dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥276.72023-03-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥202.22022-03-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥226.922021-03-01 → 2022-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥221.312020-03-01 → 2021-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥210.362019-03-01 → 2020-02-29dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥3,523.25at 2024-02-29Cons.Net assets per share (5-year summary)
Net assets per share¥3,207.14at 2023-02-28Cons.Net assets per share (5-year summary)
Net assets per share¥3,030.61at 2022-02-28dCons.Net assets per share (5-year summary)
Net assets per share¥2,791.36at 2021-02-28dCons.Net assets per share (5-year summary)
Net assets per share¥2,667.87at 2020-02-29dCons.Net assets per share (5-year summary)
Equity ratio41.8%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio43.8%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio39.1%at 2022-02-28dCons.Equity to asset ratio (5-year summary)
Equity ratio36.7%at 2021-02-28dCons.Equity to asset ratio (5-year summary)
Equity ratio38.8%at 2020-02-29dCons.Equity to asset ratio (5-year summary)
ROE8.2%2023-03-01 → 2024-02-29Cons.Rate of return on equity (5-year summary)
ROE6.5%2022-03-01 → 2023-02-28Cons.Rate of return on equity (5-year summary)
ROE7.8%2021-03-01 → 2022-02-28dCons.Rate of return on equity (5-year summary)
ROE8.1%2020-03-01 → 2021-02-28dCons.Rate of return on equity (5-year summary)
ROE8.1%2019-03-01 → 2020-02-29dCons.Rate of return on equity (5-year summary)
Employees1,431at 2024-02-29Cons.Number of employees
Employees1,297at 2023-02-28Cons.Number of employees
Employees1,325at 2022-02-28dCons.Number of employees
Employees1,304at 2021-02-28dCons.Number of employees
Employees1,187at 2020-02-29dCons.Number of employees
Revenue¥1.1bn2023-03-01 → 2024-02-29StandaloneOperating revenue1
Revenue¥1.0bn2022-03-01 → 2023-02-28StandaloneOperating revenue1
Operating income¥557m2023-03-01 → 2024-02-29StandaloneOperating income
Operating income¥491m2022-03-01 → 2023-02-28StandaloneOperating income
Ordinary income¥616m2023-03-01 → 2024-02-29StandaloneOrdinary income
Ordinary income¥592m2022-03-01 → 2023-02-28StandaloneOrdinary income
Ordinary income¥432m2021-03-01 → 2022-02-28dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥319m2020-03-01 → 2021-02-28dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥492m2019-03-01 → 2020-02-29dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥551m2023-03-01 → 2024-02-29StandaloneIncome before income taxes
Profit before tax¥613m2022-03-01 → 2023-02-28StandaloneIncome before income taxes
Net income¥457m2023-03-01 → 2024-02-29StandaloneProfit loss
Net income¥526m2022-03-01 → 2023-02-28StandaloneProfit loss
Net income¥397m2021-03-01 → 2022-02-28dStandaloneNet income loss (5-year summary)
Net income¥355m2020-03-01 → 2021-02-28dStandaloneNet income loss (5-year summary)
Net income¥311m2019-03-01 → 2020-02-29dStandaloneNet income loss (5-year summary)
Total assets¥12.7bnat 2024-02-29StandaloneAssets
Total assets¥11.8bnat 2023-02-28StandaloneAssets
Total assets¥12.5bnat 2022-02-28dStandaloneTotal assets (5-year summary)
Total assets¥12.5bnat 2021-02-28dStandaloneTotal assets (5-year summary)
Total assets¥12.4bnat 2020-02-29dStandaloneTotal assets (5-year summary)
Total liabilities¥3.7bnat 2024-02-29StandaloneLiabilities
Total liabilities¥3.2bnat 2023-02-28StandaloneLiabilities
Net assets / equity¥9.0bnat 2024-02-29StandaloneNet assets
Net assets / equity¥8.6bnat 2023-02-28StandaloneNet assets
Net assets / equity¥8.3bnat 2022-02-28dStandaloneNet assets
Net assets / equity¥8.0bnat 2021-02-28dStandaloneNet assets (5-year summary)
Net assets / equity¥8.2bnat 2020-02-29dStandaloneNet assets (5-year summary)
Cash and deposits¥1.9bnat 2024-02-29StandaloneCash and deposits
Cash and deposits¥1.8bnat 2023-02-28StandaloneCash and deposits
EPS (basic)¥121.612023-03-01 → 2024-02-29StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥140.072022-03-01 → 2023-02-28StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥105.692021-03-01 → 2022-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥94.222020-03-01 → 2021-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥81.562019-03-01 → 2020-02-29dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥452023-03-01 → 2024-02-29StandaloneDividend paid per share (5-year summary)
Dividend per share¥402022-03-01 → 2023-02-28StandaloneDividend paid per share (5-year summary)
Dividend per share¥402021-03-01 → 2022-02-28dStandaloneDividend paid per share (5-year summary)
Dividend per share¥802020-03-01 → 2021-02-28dStandaloneDividend paid per share (5-year summary)
Dividend per share¥852019-03-01 → 2020-02-29dStandaloneDividend paid per share (5-year summary)
Net assets per share¥2,385.18at 2024-02-29StandaloneNet assets per share (5-year summary)
Net assets per share¥2,293.7at 2023-02-28StandaloneNet assets per share (5-year summary)
Net assets per share¥2,196.84at 2022-02-28dStandaloneNet assets per share (5-year summary)
Net assets per share¥2,131.98at 2021-02-28dStandaloneNet assets per share (5-year summary)
Net assets per share¥2,143.92at 2020-02-29dStandaloneNet assets per share (5-year summary)
Equity ratio70.8%at 2024-02-29StandaloneEquity to asset ratio (5-year summary)
Equity ratio73.2%at 2023-02-28StandaloneEquity to asset ratio (5-year summary)
Equity ratio66.3%at 2022-02-28dStandaloneEquity to asset ratio (5-year summary)
Equity ratio64.3%at 2021-02-28dStandaloneEquity to asset ratio (5-year summary)
Equity ratio65.9%at 2020-02-29dStandaloneEquity to asset ratio (5-year summary)
ROE5.2%2023-03-01 → 2024-02-29StandaloneRate of return on equity (5-year summary)
ROE6.2%2022-03-01 → 2023-02-28StandaloneRate of return on equity (5-year summary)
ROE4.9%2021-03-01 → 2022-02-28dStandaloneRate of return on equity (5-year summary)
ROE4.4%2020-03-01 → 2021-02-28dStandaloneRate of return on equity (5-year summary)
ROE3.8%2019-03-01 → 2020-02-29dStandaloneRate of return on equity (5-year summary)
Shares issued4,070,000at 2024-02-29StandaloneTotal number of issued shares (5-year summary)
Shares issued4,070,000at 2023-02-28StandaloneTotal number of issued shares (5-year summary)
Shares issued4,070,000at 2022-02-28dStandaloneTotal number of issued shares (5-year summary)
Shares issued2,035,000at 2021-02-28dStandaloneTotal number of issued shares (5-year summary)
Shares issued2,035,000at 2020-02-29dStandaloneTotal number of issued shares (5-year summary)
Employees22at 2024-02-29StandaloneNumber of employees
Employees25at 2023-02-28StandaloneNumber of employees
Employees25at 2022-02-28dStandaloneNumber of employees
Employees25at 2021-02-28dStandaloneNumber of employees
Employees17at 2020-02-29dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 84
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2023-03-01 → 2024-02-29¥18m
Reconciling Itemsreconcilingdepreciation2023-03-01 → 2024-02-29¥32m
Reconciling Itemsreconcilingrevenue2023-03-01 → 2024-02-29−¥879m
Reconciling Itemsreconcilingrevenue intersegment2023-03-01 → 2024-02-29−¥879m
Reconciling Itemsreconcilingsegment assetsat 2024-02-29¥9.5bn
Reconciling Itemsreconcilingsegment profit2023-03-01 → 2024-02-29−¥329m
Dispensing Pharmacyreportable segmentcapex2023-03-01 → 2024-02-29¥265m
Dispensing Pharmacyreportable segmentdepreciation2023-03-01 → 2024-02-29¥174m
Dispensing Pharmacyreportable segmentemployeesat 2024-02-29463 pure
Dispensing Pharmacyreportable segmentrevenue2023-03-01 → 2024-02-29¥23.5bn
Dispensing Pharmacyreportable segmentrevenue external2023-03-01 → 2024-02-29¥23.5bn
Dispensing Pharmacyreportable segmentsegment assetsat 2024-02-29¥6.6bn
Dispensing Pharmacyreportable segmentsegment profit2023-03-01 → 2024-02-29¥1.4bn
Health Carereportable segmentcapex2023-03-01 → 2024-02-29¥32m
Health Carereportable segmentdepreciation2023-03-01 → 2024-02-29¥369m
Health Carereportable segmentemployeesat 2024-02-29755 pure
Health Carereportable segmentrevenue2023-03-01 → 2024-02-29¥7.7bn
Health Carereportable segmentrevenue external2023-03-01 → 2024-02-29¥7.7bn
Health Carereportable segmentrevenue intersegment2023-03-01 → 2024-02-29¥600,000
Health Carereportable segmentsegment assetsat 2024-02-29¥9.7bn
Health Carereportable segmentsegment profit2023-03-01 → 2024-02-29¥174m
Medical Products Wholesalereportable segmentcapex2023-03-01 → 2024-02-29¥4m
Medical Products Wholesalereportable segmentdepreciation2023-03-01 → 2024-02-29¥6m
Medical Products Wholesalereportable segmentemployeesat 2024-02-29191 pure
Medical Products Wholesalereportable segmentrevenue2023-03-01 → 2024-02-29¥9.3bn
Medical Products Wholesalereportable segmentrevenue external2023-03-01 → 2024-02-29¥8.4bn
Medical Products Wholesalereportable segmentrevenue intersegment2023-03-01 → 2024-02-29¥874m
Medical Products Wholesalereportable segmentsegment assetsat 2024-02-29¥4.2bn
Medical Products Wholesalereportable segmentsegment profit2023-03-01 → 2024-02-29¥177m
Real Estatereportable segmentcapex2023-03-01 → 2024-02-29¥2m
Real Estatereportable segmentdepreciation2023-03-01 → 2024-02-29¥32m
Real Estatereportable segmentemployeesat 2024-02-291 pure
Real Estatereportable segmentrevenue2023-03-01 → 2024-02-29¥186m
Real Estatereportable segmentrevenue external2023-03-01 → 2024-02-29¥181m
Real Estatereportable segmentrevenue intersegment2023-03-01 → 2024-02-29¥5m
Real Estatereportable segmentsegment assetsat 2024-02-29¥1.7bn
Real Estatereportable segmentsegment profit2023-03-01 → 2024-02-29¥132m
Total Of Reportable Segments And Otherssegment totalcapex2023-03-01 → 2024-02-29¥302m
Total Of Reportable Segments And Otherssegment totaldepreciation2023-03-01 → 2024-02-29¥581m
Total Of Reportable Segments And Otherssegment totalrevenue2023-03-01 → 2024-02-29¥40.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-03-01 → 2024-02-29¥39.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-03-01 → 2024-02-29¥879m
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2024-02-29¥22.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-03-01 → 2024-02-29¥1.9bn
Reconciling Itemsreconcilingcapex2022-03-01 → 2023-02-28¥26m
Reconciling Itemsreconcilingdepreciation2022-03-01 → 2023-02-28¥34m
Reconciling Itemsreconcilingrevenue2022-03-01 → 2023-02-28−¥1.0bn
Reconciling Itemsreconcilingrevenue intersegment2022-03-01 → 2023-02-28−¥1.0bn
Reconciling Itemsreconcilingsegment assetsat 2023-02-28¥7.3bn
Reconciling Itemsreconcilingsegment profit2022-03-01 → 2023-02-28−¥541m
Dispensing Pharmacyreportable segmentcapex2022-03-01 → 2023-02-28¥214m
Dispensing Pharmacyreportable segmentdepreciation2022-03-01 → 2023-02-28¥160m
Dispensing Pharmacyreportable segmentrevenue2022-03-01 → 2023-02-28¥23.1bn
Dispensing Pharmacyreportable segmentrevenue external2022-03-01 → 2023-02-28¥23.1bn
Dispensing Pharmacyreportable segmentsegment assetsat 2023-02-28¥7.8bn
Dispensing Pharmacyreportable segmentsegment profit2022-03-01 → 2023-02-28¥1.3bn
Health Carereportable segmentcapex2022-03-01 → 2023-02-28¥67m
Health Carereportable segmentdepreciation2022-03-01 → 2023-02-28¥389m
Health Carereportable segmentrevenue2022-03-01 → 2023-02-28¥7.7bn
Health Carereportable segmentrevenue external2022-03-01 → 2023-02-28¥7.7bn
Health Carereportable segmentrevenue intersegment2022-03-01 → 2023-02-28¥600,000
Health Carereportable segmentsegment assetsat 2023-02-28¥9.5bn
Health Carereportable segmentsegment profit2022-03-01 → 2023-02-28−¥29m
Medical Products Wholesalereportable segmentdepreciation2022-03-01 → 2023-02-28¥12m
Medical Products Wholesalereportable segmentrevenue2022-03-01 → 2023-02-28¥3.9bn
Medical Products Wholesalereportable segmentrevenue external2022-03-01 → 2023-02-28¥2.9bn
Medical Products Wholesalereportable segmentrevenue intersegment2022-03-01 → 2023-02-28¥998m
Medical Products Wholesalereportable segmentsegment assetsat 2023-02-28¥1.3bn
Medical Products Wholesalereportable segmentsegment profit2022-03-01 → 2023-02-28¥57m
Real Estatereportable segmentcapex2022-03-01 → 2023-02-28¥6m
Real Estatereportable segmentdepreciation2022-03-01 → 2023-02-28¥37m
Real Estatereportable segmentrevenue2022-03-01 → 2023-02-28¥189m
Real Estatereportable segmentrevenue external2022-03-01 → 2023-02-28¥187m
Real Estatereportable segmentrevenue intersegment2022-03-01 → 2023-02-28¥2m
Real Estatereportable segmentsegment assetsat 2023-02-28¥1.6bn
Real Estatereportable segmentsegment profit2022-03-01 → 2023-02-28¥125m
Total Of Reportable Segments And Otherssegment totalcapex2022-03-01 → 2023-02-28¥286m
Total Of Reportable Segments And Otherssegment totaldepreciation2022-03-01 → 2023-02-28¥598m
Total Of Reportable Segments And Otherssegment totalrevenue2022-03-01 → 2023-02-28¥34.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-03-01 → 2023-02-28¥33.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-03-01 → 2023-02-28¥1.0bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-02-28¥20.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-03-01 → 2023-02-28¥1.5bn
Real Estatereportable segmentemployeesat 2024-02-291 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,510
ItemContextValueUnit
Other clCurrentYearInstant820856000JPY
Current liabilitiesPrior1YearInstant7454768000JPY
Current liabilitiesCurrentYearInstant10404006000JPY
Long term loans payablePrior1YearInstant6062910000JPY
Long term loans payableCurrentYearInstant5717480000JPY
Lease obligations nclPrior1YearInstant189717000JPY
Lease obligations nclCurrentYearInstant166606000JPY
Net defined benefit liabilityPrior1YearInstant802137000JPY
Net defined benefit liabilityCurrentYearInstant1016554000JPY
Other nclPrior1YearInstant388400000JPY
Other nclCurrentYearInstant513653000JPY
Noncurrent liabilitiesPrior1YearInstant7443165000JPY
Noncurrent liabilitiesCurrentYearInstant7414294000JPY
LiabilitiesPrior1YearInstant14897934000JPY
LiabilitiesCurrentYearInstant17818300000JPY
Capital stockPrior1YearInstant917000000JPY
Capital stockCurrentYearInstant917000000JPY
Capital surplusPrior1YearInstant1081272000JPY
Capital surplusCurrentYearInstant1081749000JPY
Retained earningsPrior1YearInstant10557964000JPY
Retained earningsCurrentYearInstant11447448000JPY
Treasury stockPrior1YearInstant-539830000JPY
Treasury stockCurrentYearInstant-537933000JPY
Shareholders equityPrior1YearInstant12016406000JPY
Shareholders equityCurrentYearInstant12908264000JPY
Valuation difference on available for sale securitiesPrior1YearInstant27858000JPY
Valuation difference on available for sale securitiesCurrentYearInstant332990000JPY
Remeasurements of defined benefit plansPrior1YearInstant5068000JPY
Remeasurements of defined benefit plansCurrentYearInstant-406000JPY
Valuation and translation adjustmentsPrior1YearInstant32926000JPY
Valuation and translation adjustmentsCurrentYearInstant332584000JPY
Non controlling interestsPrior1YearInstant558509000JPY
Non controlling interestsCurrentYearInstant600341000JPY
Net assetsPrior1YearInstant12607842000JPY
Net assetsCurrentYearInstant13841190000JPY
Liabilities and net assetsPrior1YearInstant27505776000JPY
Liabilities and net assetsCurrentYearInstant31659490000JPY
Net salesPrior1YearDuration33897598000JPY
Net salesCurrentYearDuration39900988000JPY
Cost of salesPrior1YearDuration30714910000JPY
Cost of salesCurrentYearDuration35349135000JPY
Gross profitPrior1YearDuration3182687000JPY
Gross profitCurrentYearDuration4551853000JPY
Selling general and administrative expensesPrior1YearDuration2247517000JPY
Selling general and administrative expensesCurrentYearDuration2992629000JPY
Operating incomePrior1YearDuration935169000JPY
Operating incomeCurrentYearDuration1559223000JPY
Interest income noiPrior1YearDuration1105000JPY
Interest income noiCurrentYearDuration1650000JPY
Dividends income noiPrior1YearDuration38053000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 22 of 22 passed
balance sheet identityconsolidated 2023-02-28pass
balance sheet identityconsolidated 2024-02-29pass
balance sheet identitynon_consolidated 2023-02-28pass rounding
balance sheet identitynon_consolidated 2024-02-29pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-02-28pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net assetsnon_consolidated 2022-02-28pass
statement vs summary · net assetsnon_consolidated 2023-02-28pass
statement vs summary · net assetsnon_consolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-03-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-03-01/2024-02-29pass
statement vs summary · operating cash flowconsolidated 2022-03-01/2023-02-28pass
statement vs summary · operating cash flowconsolidated 2023-03-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-03-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-03-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-02-28pass
statement vs summary · total assetsconsolidated 2024-02-29pass
statement vs summary · total assetsnon_consolidated 2023-02-28pass
statement vs summary · total assetsnon_consolidated 2024-02-29pass